Consumption of Sustainable Medications and its Impact on Health

• Autorzy: Katarzyna Szalonka , Piotr Stańczyk
• Języki publikacji: EN

Abstrakty

EN

Sustainable consumption of medicines is medically justifi ed medicine consumption, indispensable in the treatment process, which contributes to the quality of life of the patient and extends the patient's life resulting from the doctor's recommendations and verifi ed by the pharmacist elimination of medicine interactions. The aim of this paper is to analyze diff erences in the level of medicines consumption in Poland and in the wider world, and its impact on life expectancy and health status. There is a large variation in the per capita medicine intake in certain countries. The following hypothesis was formulated in the paper: the consumption of medicines is not related to the health and longevity of the inhabitants. The article is based on secondary research and a statistical analysis of medicine consumption in selected countries in the years 2015-2018. Also presented are the results of research regarding the consumption of medicines in terms of quantity and value in Poland against the background of selected countries and also in regional location in the context of socio-economic conditions. (original abstract)

Słowa kluczowe

EN

Sustainable consumption; Medications; Life expectancy

PL

Konsumpcja zrównoważona; Leki; Długość życia

• Czasopismo: Ekonomia - Wroclaw Economic Review
• Rocznik: 2019
• Numer: tom 25, nr 4
• Strony: 85--99

Twórcy

autor

Katarzyna Szalonka

• University of Wrocław

autor

Piotr Stańczyk

• Wrocław University of Economics

Bibliografia

• Act of 6 September 2001, Pharmaceutical Law, Law Journal 2001, No. 126, item 1391.
• Hepler, C., Strand, L. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47(3), 533-543.
• Kardas, P. (2010). Nieprzestrzeganie zaleceń terapeutycznych na świecie i w Polsce. In Polskiego pacjenta portret własny. Raport o przestrzeganiu zaleceń terapeutycznych przez polskich pacjentów [Polish patient's self-portrait. Report on compliance with therapeutic recommenda-tions by Polish patients]. Fundacja Polpharmy na rzecz Wspierania Rozwoju Polskiej Farmacji i Medycyny [Polpharma Foundation for the Development of Polish Pharmacy and Medicine]. Warszawa: Pentor International.
• Pharma Expert database. Retrieved September 1, 2018 from http://www.aptekarzpolski.pl/2016/11/rynek-apteczny-w-pazdzierniku-2016.
• Szalonka, K. (2014). Pożądane zachowania zdrowotne polskich gospodarstw domowych. Zeszyty Naukowe Polityki Europejskie, Finanse i Marketing, 12, 199-208. Retrieved September 1, 2018 from http://www.wne.sggw.pl/czasopisma/pdf/PEFIM_2014_T12_nr61.pdf.
• Szalonka, K., Krajewska-Smardz, A. (2015). Rola marketingu w procesie wdrażania innowacyj-nych produktów farmaceutycznych w Polsce. Logistyka, 2, 1077-1082.

Identyfikatory

DOI

10.19195/2658-1310.25.4.6